Capital Fund Management (CFM)’s Idexx Laboratories IDXX Stock Holding History

Capital Fund Management (CFM)’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,900	Closed	-$789K	–	1916
2019 Q3	$789K	Sell	2,900 -14,600	-83%	-$4.06M	0.01%	1084
2019 Q2	$4.82M	Buy	17,500 +8,700	+99%	+$2.14M	0.04%	524
2019 Q1	$1.97M	Buy	8,800 +7,500	+577%	+$1.55M	0.02%	817
2018 Q4	$242K	Sell	1,300 -85,500	-99%	-$17.5M	﹤0.01%	1684
2018 Q3	$21.7M	Buy	86,800 +24,500	+39%	+$5.95M	0.12%	243
2018 Q2	$13.6M	Buy	62,300 +58,600	+1,584%	+$12.1M	0.07%	382
2018 Q1	$708K	Sell	3,700 -5,500	-60%	-$1.02M	﹤0.01%	1344
2017 Q4	$1.44M	Sell	9,200 -2,300	-20%	-$362K	0.01%	1084
2017 Q3	$1.79M	Buy	+11,500	New	+$1.82M	0.01%	799

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s IDXX Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Idexx Laboratories (IDXX) stake by 5.2% in Q1 2026, selling an estimated $1.5M and leaving 42,889 shares worth $24.1M. The position accounts for 0.11% of the portfolio, ranked #253.

Capital Fund Management (CFM) first reported a position in IDXX in Q3 2014 and has held it in 25 quarters since. The position peaked at $30.6M in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Capital Fund Management (CFM) held 42,889 shares of Idexx Laboratories worth $24.1M as of Q1 2026.
Capital Fund Management (CFM) sold 2,332 Idexx Laboratories shares in Q1 2026, an estimated $1.5M.
Idexx Laboratories made up 0.11% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #253 holding.
Capital Fund Management (CFM) first reported a position in Idexx Laboratories in Q3 2014 and has held it in 25 quarters since.
Capital Fund Management (CFM)'s Idexx Laboratories position peaked at $30.6M in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.